{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:45:55Z","timestamp":1787755555519,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Family Med Prim Care"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jfmpc.jfmpc_1026_20","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T08:39:06Z","timestamp":1613723946000},"page":"5971","source":"Crossref","is-referenced-by-count":7,"title":["Outcome of therapeutic plasma exchange in Myasthenia gravis patients"],"prefix":"10.4103","volume":"9","author":[{"given":"Kaushik","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2249-4863.305550-1","doi-asserted-by":"crossref","unstructured":"Gilcher RO, Smith JW. Apheresis: Principles and technology of hemapheresis. In: Simon TI, Synder EL, Solheim C, Stowell P, Strauss G, Petrides M, editors. Rossi's Principles of Transfusion Medicine. USA: Wiley-Blackwell; 2009. p. 617-28.","DOI":"10.1002\/9781444303513.ch41"},{"key":"key-10.4103\/2249-4863.305550-2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: A systematic literature review","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"key-10.4103\/2249-4863.305550-3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jca.2920080402","article-title":"An overview of current management","author":"Strauss","year":"1993","journal-title":"J Clin Apher"},{"key":"key-10.4103\/2249-4863.305550-4","first-page":"840","article-title":"Report of the therapeutics and technology assessment subcommittee of the American academy of neurology","author":"Assessment","year":"1996","journal-title":"Neurology"},{"key":"key-10.4103\/2249-4863.305550-5","doi-asserted-by":"crossref","unstructured":"Smith JW, Weinstein R, Hillyer KL. AABB hemapheresis committee. American society for apheresis. Therapeutic apheresis: A summary of current indication categories endorsed by the AABB and the American society for apheresis. Transfusion 2003;43:820-2.","DOI":"10.1046\/j.1537-2995.2003.00397.x"},{"key":"key-10.4103\/2249-4863.305550-6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the writing committee of the American society for apheresis: The eighth special issue","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"key-10.4103\/2249-4863.305550-7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","article-title":"Therapeutic plasma exchange: Core curriculum 2008","author":"Kaplan","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/2249-4863.305550-8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM197903083001003","article-title":"Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange","author":"Lockwood","year":"1979","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2249-4863.305550-9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(79)90823-7","article-title":"Long-term effects of repeated plasma exchange in myasthenia gravis","author":"Newsom-Davis","year":"1979","journal-title":"Lancet"},{"key":"key-10.4103\/2249-4863.305550-10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CND.0b013e31822c34dd","article-title":"Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: An acute hospital cost comparison study","author":"Heatwole","year":"2011","journal-title":"J Clin Neuromuscul Dis"},{"key":"key-10.4103\/2249-4863.305550-11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV immunoglobulin in patients with myasthenia gravis: A randomized controlled trial","author":"Zinman","year":"2007","journal-title":"Neurology"},{"key":"key-10.4103\/2249-4863.305550-12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"key-10.4103\/2249-4863.305550-13","first-page":"M597","article-title":"A simple and accurate method for prescribing plasma exchange","author":"Kaplan","year":"1990","journal-title":"ASAIO Trans"},{"key":"key-10.4103\/2249-4863.305550-14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","author":"Pinching","year":"1976","journal-title":"Lancet"},{"key":"key-10.4103\/2249-4863.305550-15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","article-title":"Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis","author":"Dau","year":"1977","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2249-4863.305550-16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange","author":"Newsom-Davis","year":"1978","journal-title":"Neurology"},{"key":"key-10.4103\/2249-4863.305550-17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis.Myasthenia gravis clinical study group","author":"Gajdos","year":"1997","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2249-4863.305550-18","first-page":"CD002275","article-title":"Plasma exchange for myasthenia gravis?","author":"Gajdos","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2249-4863.305550-19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2014.17","article-title":"Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis","author":"Liew","year":"2014","journal-title":"JAMA Neurol"},{"key":"key-10.4103\/2249-4863.305550-20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1525-1594.2001.06717.x","article-title":"Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis","author":"R\u00f8nager","year":"2001","journal-title":"Artif Organs"},{"key":"key-10.4103\/2249-4863.305550-21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","author":"Farmakidis","year":"2018","journal-title":"Neurol Clin"},{"key":"key-10.4103\/2249-4863.305550-22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fneur.2020.00743","article-title":"Management of juvenile myasthenia gravis","author":"O'Connell","year":"2020","journal-title":"Front Neurol"},{"key":"key-10.4103\/2249-4863.305550-23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00003246-199707000-00027","article-title":"Therapy of myasthenic crisis","author":"Berrouschot","year":"1997","journal-title":"Crit Care Med"},{"key":"key-10.4103\/2249-4863.305550-24","first-page":"203","article-title":"Clinical profile and outcome of myathenic crisis in a tertiary care hospital: A prospective study","author":"Sharma","year":"2013","journal-title":"Ann Indian Acad Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"key-10.4103\/2249-4863.305550-25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1385\/NCC:3:3:213","article-title":"Risk of extubation failure in patients with myasthenic crisis","author":"Rabinstein","year":"2005","journal-title":"Neurocrit Care"},{"key":"key-10.4103\/2249-4863.305550-26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-1331.1998.520137.x","article-title":"The management and outcome of patients with myasthenia gravis treated acutely in a neurological intensive care unit","author":"O'Riordan","year":"1998","journal-title":"Eur J Neurol"},{"key":"key-10.4103\/2249-4863.305550-27","first-page":"9","article-title":"Therapeutic plasma exchange in the treatment of myasthenia gravis","author":"Kumar","year":"2015","journal-title":"Indian J Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/0972-5229","issn-type":"print"},{"key":"key-10.4103\/2249-4863.305550-28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0749-0704(01)00010-0","article-title":"Plasmapheresis.Technical aspects and indications","author":"Madore","year":"2002","journal-title":"Crit Care Clin"},{"key":"key-10.4103\/2249-4863.305550-29","unstructured":"Davenport RD. Apheresis Principles and Practice. 2nd ed.. In: McLeod BC, editor. Bethesda: AABB; 2003."},{"key":"key-10.4103\/2249-4863.305550-30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jca.1024","article-title":"Adverse reactions associated with mobile therapeutic apheresis: Analysis of 17,940 procedures","author":"Kiprov","year":"2001","journal-title":"J Clin Apher"},{"key":"key-10.4103\/2249-4863.305550-31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jca.21257","article-title":"Therapeutic plasma exchange: A technical and operational review","author":"Kaplan","year":"2013","journal-title":"J Clin Apher"},{"key":"key-10.4103\/2249-4863.305550-32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0272-6386(12)80135-1","article-title":"Therapeutic plasma exchange: Complications and management","author":"Mokrzycki","year":"1994","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:02:41Z","timestamp":1786734161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1026_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"alternative-id":["305550"],"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1026_20","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}